Tag: SURPASS-CVOT
-

Eli Lilly Wins FDA Approval for Mounjaro to Reduce Cardiovascular Risk
The FDA approved Mounjaro (tirzepatide) to reduce major cardiovascular events in adults with type 2 diabetes at high cardiovascular risk.

The FDA approved Mounjaro (tirzepatide) to reduce major cardiovascular events in adults with type 2 diabetes at high cardiovascular risk.